相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oxidation-strengthened disulfide-bridged prodrug nanoplatforms with cascade facilitated drug release for synergetic photochemotherapy
Bin Yang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Localized Controlled Release of Bilirubin from β-Cyclodextrin-Conjugated ε-Polylysine To Attenuate Oxidative Stress and Inflammation in Transplanted Islets
Qing Yao et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
Eric C. Cheung et al.
CANCER CELL (2020)
Endocytosis of ATB0,+(SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer
Longfa Kou et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer
Austin R. Dosch et al.
MOLECULAR CANCER RESEARCH (2020)
The role of transporters in cancer redox homeostasis and cross-talk with nanomedicines
Longfa Kou et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy
Longfa Kou et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid
Jingwei Shao et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedside
Alberto Gabizon et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Bilirubin Protects Transplanted Islets by Targeting Ferroptosis
Qing Yao et al.
FRONTIERS IN PHARMACOLOGY (2020)
Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies
Farshad Moradi Kashkooli et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Nanoparticle mediated codelivery of nifuratel and doxorubicin for synergistic anticancer therapy through STAT3 inhibition
Hailun Zheng et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn2+ and Synergistic Antitumor Efficacy
Ying-Zheng Zhao et al.
MOLECULAR PHARMACEUTICS (2020)
Hypoxia-activated ROS burst liposomes boosted by local mild hyperthermia for photo/chemodynamic therapy
Xiang-long Tang et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Tumor microenvironment-responsive and oxygen self-sufficient oil droplet nanoparticles for enhanced photothermal/photodynamic combination therapy against hypoxic tumors
Reesha Kv et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Bioinspired biliverdin/silk fibroin hydrogel for antiglioma photothermal therapy and wound healing
Qing Yao et al.
THERANOSTICS (2020)
Intestinal Absorption of Isoalantolactone and Alantolactone, Two Sesquiterpene Lactones from Radix Inulae, Using Caco-2 Cells
Renjie Xu et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R. Halfdanarson et al.
ONCOLOGIST (2019)
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
Maria Teresa Blasco et al.
CANCER CELL (2019)
Ambidextrous Approach To Disrupt Redox Balance in Tumor Cells with Increased ROS Production and Decreased GSH Synthesis for Cancer Therapy
Longfa Kou et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells
Xiaoguang Xu et al.
LIFE SCIENCES (2019)
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
Dannielle D. Engle et al.
SCIENCE (2019)
Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma
Xiang Lu Ji et al.
AGING-US (2019)
Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes
Shu Han et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model
Changtian Yin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
Hailun Zheng et al.
MOLECULAR CARCINOGENESIS (2019)
Modulating intestinal mucus barrier for nanoparticles penetration by surfactants
Xin Zhang et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Berbamine Enhances the Efficacy of Gefitinib by Suppressing STAT3 Signaling in Pancreatic Cancer Cells
Bingren Hu et al.
ONCOTARGETS AND THERAPY (2019)
Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas
Hui-Min Lei et al.
THERANOSTICS (2019)
ROS mediated EGFR/MEK/ERK/HIF-1α Loop Regulates Glucose metabolism in pancreatic cancer
Gang Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
IL22RA1/STAT3 Signaling Promotes Stemness and Tumorigenicity in Pancreatic Cancer
Weizhi He et al.
CANCER RESEARCH (2018)
MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting
Qing Yao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase
Jiang-Kai Dong et al.
THERANOSTICS (2018)
Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine
Manendra Babu Lankadasari et al.
THERANOSTICS (2018)
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
Longfa Kou et al.
FRONTIERS IN PHARMACOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway
Li Cui et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles
Qing Yao et al.
MOLECULAR PHARMACEUTICS (2017)
Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs
Longfa Kou et al.
ADVANCED HEALTHCARE MATERIALS (2017)
Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism
Chengguang Zhao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
Meng Guo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells
Jaemoo Chun et al.
CANCER LETTERS (2015)
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
Wei Wen et al.
MOLECULAR CANCER (2015)
Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells
Atsushi Sato et al.
STEM CELL RESEARCH (2014)
Hydrogen peroxide sensing, signaling and regulation of transcription factors
H. Susana Marinho et al.
REDOX BIOLOGY (2014)
Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression
Chunhui Yang et al.
IUBMB LIFE (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Longfa Kou et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Endocytosis of nanomedicines
Gaurav Sahay et al.
JOURNAL OF CONTROLLED RELEASE (2010)
分享论文
